BioCentury
ARTICLE | Financial News

Aldagen amends IPO

May 10, 2010 7:00 AM UTC

Aldagen Inc., Durham, N.C. Business: Gene/Cell therapy Date announced: 5/5/10 Type: IPO To be raised: Up to $80.5 million Price: TBD Underwriters: Boenning & Scattergood Inc.; Ladenburg Thalmann; Nati...